Metoclopramidhydrochlorid Noridem (Metoclopramide Hydrochloride Monohydrate)

Metoclopramide Hydrochloride acts on the dopaminergic pathways that trigger nausea and delay gastric emptying. It is indicated for several gastrointestinal and postoperative conditions.

• Nausea and vomiting: reduces the frequency and severity of acute and chemotherapy‑induced episodes.
• Gastroparesis: enhances gastric motility and promotes more efficient stomach emptying.
• Postoperative nausea: prevents or treats nausea following surgical procedures.

• Metoclopramide Hydrochloride blocks dopamine D2 receptors in the chemoreceptor trigger zone, diminishing the central vomiting stimulus, while simultaneously increasing acetylcholine release in the gastrointestinal tract, which augments smooth‑muscle contractility and accelerates gastric emptying.

Metoclopramide Hydrochloride may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Drowsiness: mild sedation or sleepiness.
• Fatigue: general feeling of tiredness.
• Restlessness: inner sense of unease or agitation.
• Diarrhea: loose or frequent stools.
• Headache: mild to moderate cranial pain.
• Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects

• Extrapyramidal reactions: involuntary muscle movements or rigidity.
• Tardive dyskinesia: persistent, potentially irreversible facial or tongue movements.
• Neuroleptic malignant syndrome: rare, life‑threatening hyperthermic reaction.
• Severe allergic reactions: rash, swelling, or anaphylaxis.
• Depression or suicidal thoughts: mood alterations requiring immediate attention.
• Seizures: rare convulsive episodes.

Before initiating therapy with Metoclopramide Hydrochloride, clinicians should consider several safety aspects.

• Assess renal function: adjust use in severe renal impairment.
• Monitor for extrapyramidal symptoms: observe patients for involuntary movements.
• Avoid in patients with known hypersensitivity: discontinue if allergic reaction occurs.
• Use cautiously in elderly: increased risk of sedation and falls.
• Store at ambient temperature: keep in original container, protect from moisture and light.

Metoclopramide Hydrochloride can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Anticholinergic agents: may reduce the pro‑kinetic effect.
• CYP450 inhibitors (e.g., ketoconazole): increase plasma concentrations of metoclopramide.
• Other dopamine antagonists: additive risk of extrapyramidal symptoms.

Moderate Interactions (Monitor Closely)

• Opioids: may enhance nausea control but increase sedation.
• Serotonergic drugs: low risk of serotonin syndrome, monitor for symptoms.
• Alcohol: may potentiate central nervous system depression.